Inhibikase Therapeutics Reports Third Quarter Financial Results and Highlights Recent Activity
Detailed price information for Inhibikase Therapeutics Inc (IKT-Q) from The Globe and Mail including charting and trades.
Inhibikase: Potential To Improve Current Treatment Options For PAH Patients
News on Inhibikase's promising treatments for PAH and Parkinson's Disease, supported by FDA approval and substantial funding.